Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janosch Achenbach

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Future Medicinal Chemistry|June 29, 2011
Computational tools for polypharmacology and repurposingJanosch Achenbach, Pekka Tiikkainen, Lutz Franke, et al.
Journal of Medicinal Chemistry|June 6, 2013
VAMMPIRE: a matched molecular pairs database for structure-based drug design and optimizationJulia Weber, Janosch Achenbach, Daniel Moser, et al.
Journal of Chemical Information and Modeling|January 29, 2015
VAMMPIRE-LORD: a web server for straightforward lead optimization using matched molecular pairsJulia Weber, Janosch Achenbach, Daniel Moser, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2017
DrugBank screening revealed alitretinoin and bexarotene as liver X receptor modulatorsPascal Heitel, Janosch Achenbach, Daniel Moser, et al.
Biochemical Pharmacology|March 15, 2012
Investigation of imatinib and other approved drugs as starting points for antidiabetic drug discovery with FXR modulating activityRamona Steri, Janosch Achenbach, Dieter Steinhilber, et al.
Pest Management Science|January 30, 2016
Emergence of succinate dehydrogenase inhibitor resistance of Pyrenophora teres in EuropeAlexandra Rehfus, Simone Miessner, Janosch Achenbach, et al.
Toxicology Letters|January 23, 2016
Synthetic cannabinoids: In silico prediction of the cannabinoid receptor 1 affinity by a quantitative structure-activity relationship modelAlexander Paulke, Ewgenij Proschak, Kai Sommer, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2012
Evaluation of structure-derived pharmacophore of soluble epoxide hydrolase inhibitors by virtual screeningDaniel Moser, Janosch Achenbach, Franca-Maria Klingler, et al.
Journal of Chemical Information and Modeling|January 28, 2015
PENG: a neural gas-based approach for pharmacophore elucidation. method design, validation, and virtual screening for novel ligands of LTA4HDaniel Moser, Sandra K Wittmann, Jan Kramer, et al.
Bioorganic & Medicinal Chemistry|October 13, 2016
Pyrazolo[1,5a]pyrimidines as a new class of FUSE binding protein 1 (FUBP1) inhibitorsStefanie Hauck, Kerstin Hiesinger, Sabrina Khageh Hosseini, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Future Medicinal Chemistry|June 29, 2011
Computational tools for polypharmacology and repurposingJanosch Achenbach, Pekka Tiikkainen, Lutz Franke, et al.
Journal of Medicinal Chemistry|June 6, 2013
VAMMPIRE: a matched molecular pairs database for structure-based drug design and optimizationJulia Weber, Janosch Achenbach, Daniel Moser, et al.
Journal of Chemical Information and Modeling|January 29, 2015
VAMMPIRE-LORD: a web server for straightforward lead optimization using matched molecular pairsJulia Weber, Janosch Achenbach, Daniel Moser, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2017
DrugBank screening revealed alitretinoin and bexarotene as liver X receptor modulatorsPascal Heitel, Janosch Achenbach, Daniel Moser, et al.
Biochemical Pharmacology|March 15, 2012
Investigation of imatinib and other approved drugs as starting points for antidiabetic drug discovery with FXR modulating activityRamona Steri, Janosch Achenbach, Dieter Steinhilber, et al.
Pest Management Science|January 30, 2016
Emergence of succinate dehydrogenase inhibitor resistance of Pyrenophora teres in EuropeAlexandra Rehfus, Simone Miessner, Janosch Achenbach, et al.
Toxicology Letters|January 23, 2016
Synthetic cannabinoids: In silico prediction of the cannabinoid receptor 1 affinity by a quantitative structure-activity relationship modelAlexander Paulke, Ewgenij Proschak, Kai Sommer, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2012
Evaluation of structure-derived pharmacophore of soluble epoxide hydrolase inhibitors by virtual screeningDaniel Moser, Janosch Achenbach, Franca-Maria Klingler, et al.
Journal of Chemical Information and Modeling|January 28, 2015
PENG: a neural gas-based approach for pharmacophore elucidation. method design, validation, and virtual screening for novel ligands of LTA4HDaniel Moser, Sandra K Wittmann, Jan Kramer, et al.
Bioorganic & Medicinal Chemistry|October 13, 2016
Pyrazolo[1,5a]pyrimidines as a new class of FUSE binding protein 1 (FUBP1) inhibitorsStefanie Hauck, Kerstin Hiesinger, Sabrina Khageh Hosseini, et al.
Pageof 2